Correlation between treatment-induced changes in lumbar motor control and N150 amplitude. by Soheila Qanbari (20455173)

Subjects:

The mean and standard deviation of outcome measures. by Soheila Qanbari (20455173)

Subjects:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

Subjects:

The demographical and clinical characteristics of subjects at baseline. by Soheila Qanbari (20455173)

Subjects:

Electrode montage and electric field distribution simulated with SimNIBS software. by Soheila Qanbari (20455173)

Subjects:

ALKG1202R –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

RT-qPCR Primer. by Dequan Wang (6007007)

Subjects:

ALKC1156Y –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

CCND1 is a target gene of miR-1247-3p. by Dequan Wang (6007007)

Subjects:

S1 Data - by Richard Junior Zapata Dongo (17912565)

Subjects:

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

Subjects:

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

Subjects:

Ba/F3 EML4-ALK^mutants exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

Subjects:

miR-1247-3p plasmid. by Dequan Wang (6007007)

Subjects:

Molecular docking showed that ABT-199 can fit into active site of ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

Subjects:

RNA-sequencing data screening for miR-1247-3p target genes. by Dequan Wang (6007007)

Subjects:

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

Subjects:

Dual luciferase primer. by Dequan Wang (6007007)

Subjects:

shCCND1 plasmid. by Dequan Wang (6007007)

Subjects:

CCND1 promoted chemoresistance in CRC. by Dequan Wang (6007007)

Subjects: